In addition, vactosertib inhibited TGF-β-stimulated TIMP-1 secretion by HSCs, as well as the TIMP-1-induced proliferation, motility, and survival of HCC cell lines (SK-HEP1, SNU354, and HepG2). Here, TIMP1 is linked to hepatocellular carcinoma.